419 related articles for article (PubMed ID: 22482474)
1. Percutaneous alcohol septal ablation for hypertrophic obstructive cardiomyopathy: technical review and long-term clinical and echocardiographic outcomes.
Leal S; Galeote G; Jiménez-Valero S; Sánchez-Recalde A; Salinas P; Ruiz AS; Orbe LC; Dominguéz F; Moreno R; López-Sendón JL
Rev Port Cardiol; 2012 May; 31(5):363-71. PubMed ID: 22482474
[TBL] [Abstract][Full Text] [Related]
2. Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy: A 16-Year Australian Single Centre Experience.
Nogic J; Koh Y; Bak M; Gooley RP; Meredith IT; McCormick LM
Heart Lung Circ; 2018 Dec; 27(12):1446-1453. PubMed ID: 29129561
[TBL] [Abstract][Full Text] [Related]
3. Long-term clinical follow-up of patients undergoing percutaneous alcohol septal reduction for symptomatic obstructive hypertrophic cardiomyopathy.
Fortunato de Cano S; Nicolas Cano M; de Ribamar Costa J; Alves Pinheiro J; Bellio de Mattos Barretto R; Costa de Souza Le Bihan D; Abizaid A; Sousa A; Eduardo Sousa J
Catheter Cardiovasc Interv; 2016 Nov; 88(6):953-960. PubMed ID: 27143093
[TBL] [Abstract][Full Text] [Related]
4. Time to significant gradient reduction following septal balloon occlusion predicts the magnitude of final gradient response during alcohol septal ablation in patients with hypertrophic obstructive cardiomyopathy.
Almasood A; Garceau P; Woo A; Rakowski H; Schwartz L; Overgaard CB
JACC Cardiovasc Interv; 2011 Sep; 4(9):1030-4. PubMed ID: 21939945
[TBL] [Abstract][Full Text] [Related]
5. Alcohol septal ablation for hypertrophic obstructive cardiomyopathy: a systematic review of published studies.
Alam M; Dokainish H; Lakkis N
J Interv Cardiol; 2006 Aug; 19(4):319-27. PubMed ID: 16881978
[TBL] [Abstract][Full Text] [Related]
6. Relation of immediate decrease in ventricular septal strain after alcohol septal ablation for obstructive hypertrophic cardiomyopathy to long-term reduction in left ventricular outflow tract pressure gradient.
van Ramshorst J; Mollema SA; Delgado V; van der Wall EE; Schalij MJ; Atsma DE; Bax JJ
Am J Cardiol; 2009 Jun; 103(11):1592-7. PubMed ID: 19463521
[TBL] [Abstract][Full Text] [Related]
7. Long-term clinical and echocardiographic outcomes of extensive septal myectomy for hypertrophic obstructive cardiomyopathy in Chinese patients.
Yao L; Li L; Lu XJ; Miao YL; Kang XN; Duan FJ
Cardiovasc Ultrasound; 2016 May; 14(1):18. PubMed ID: 27189485
[TBL] [Abstract][Full Text] [Related]
8. Hypertrophic obstructive cardiomyopathy-alcohol septal ablation vs. myectomy: a meta-analysis.
Alam M; Dokainish H; Lakkis NM
Eur Heart J; 2009 May; 30(9):1080-7. PubMed ID: 19233857
[TBL] [Abstract][Full Text] [Related]
9. Short- and long-term outcome after alcohol septal ablation in obstructive hypertrophic cardiomyopathy: Experience of a reference center.
Aguiar Rosa S; Fiarresga A; Galrinho A; Cacela D; Ramos R; de Sousa L; Gonçalves A; Bernardes L; Patrício L; Branco LM; Ferreira RC
Rev Port Cardiol (Engl Ed); 2019 Jul; 38(7):473-480. PubMed ID: 31495717
[TBL] [Abstract][Full Text] [Related]
10. Looking back on 15 years of ultrasound-guided alcohol septal ablation for hypertrophic obstructive cardiomyopathy.
Vermaete I; Dujardin K; Stammen F
Acta Cardiol; 2020 Oct; 75(6):483-491. PubMed ID: 31204591
[No Abstract] [Full Text] [Related]
11. Long-term outcomes of septal reduction for obstructive hypertrophic cardiomyopathy.
Sedehi D; Finocchiaro G; Tibayan Y; Chi J; Pavlovic A; Kim YM; Tibayan FA; Reitz BA; Robbins RC; Woo J; Ha R; Lee DP; Ashley EA
J Cardiol; 2015 Jul; 66(1):57-62. PubMed ID: 25238885
[TBL] [Abstract][Full Text] [Related]
12. Predictors of Outcome After Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy: An Echocardiography and Cardiovascular Magnetic Resonance Imaging Study.
Lu M; Du H; Gao Z; Song L; Cheng H; Zhang Y; Yin G; Chen X; Ling J; Jiang Y; Wang H; Li J; Huang J; He Z; Zhao S
Circ Cardiovasc Interv; 2016 Mar; 9(3):e002675. PubMed ID: 26884612
[TBL] [Abstract][Full Text] [Related]
13. Long-term outcomes in high-risk symptomatic patients with hypertrophic cardiomyopathy undergoing alcohol septal ablation.
Kwon DH; Kapadia SR; Tuzcu EM; Halley CM; Gorodeski EZ; Curtin RJ; Thamilarasan M; Smedira NG; Lytle BW; Lever HM; Desai MY
JACC Cardiovasc Interv; 2008 Aug; 1(4):432-8. PubMed ID: 19463341
[TBL] [Abstract][Full Text] [Related]
14. Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: Acute results and three-year noninvasive follow-up in 18 patients.
Guo H; Wang J; Chen J; Shan J; Lee JD; Ueda T
Can J Cardiol; 2004 Jun; 20(8):779-82. PubMed ID: 15229758
[TBL] [Abstract][Full Text] [Related]
15. Surgical septal myectomy or alcohol septal ablation: which approach offers better outcomes for patients with hypertrophic obstructive cardiomyopathy?
Poon SS; Field M; Gupta D; Cameron D
Interact Cardiovasc Thorac Surg; 2017 Jun; 24(6):951-961. PubMed ID: 28329292
[TBL] [Abstract][Full Text] [Related]
16. [Clinical and echocardiographic follow-up of patients with hypertrophic obstructive cardiomyopathy treated by percutaneous septal ablation].
Delgado V; Sitges M; Andrea R; Rivera S; Masotti M; Francino A; Azqueta M; Paré C; Betriu A
Rev Esp Cardiol; 2006 Nov; 59(11):1123-30. PubMed ID: 17144987
[TBL] [Abstract][Full Text] [Related]
17. Reduction of left ventricular mass, left atrial size, and N-terminal pro-B-type natriuretic peptide level following alcohol septal ablation in patients with hypertrophic obstructive cardiomyopathy.
Dąbrowski M; Kukuła K; Kłopotowski M; Bekta P; Śpiewak M; Mazurkiewicz Ł; Tyczyński P; Orczykowski M; Parma R; Witkowski A
Kardiol Pol; 2019; 77(2):181-189. PubMed ID: 30566209
[TBL] [Abstract][Full Text] [Related]
18. A novel approach in the use of radiofrequency catheter ablation of septal hypertrophy in hypertrophic obstructive cardiomyopathy.
Shelke AB; Menon R; Kapadiya A; Yalagudri S; Saggu D; Nair S; Narasimhan C
Indian Heart J; 2016; 68(5):618-623. PubMed ID: 27773399
[TBL] [Abstract][Full Text] [Related]
19. Hypertrophic obstructive cardiomyopathy: comparison of outcomes after myectomy or alcohol ablation adjusted by propensity score.
Ralph-Edwards A; Woo A; McCrindle BW; Shapero JL; Schwartz L; Rakowski H; Wigle ED; Williams WG
J Thorac Cardiovasc Surg; 2005 Feb; 129(2):351-8. PubMed ID: 15678046
[TBL] [Abstract][Full Text] [Related]
20. Current effectiveness and risks of isolated septal myectomy for hypertrophic obstructive cardiomyopathy.
Smedira NG; Lytle BW; Lever HM; Rajeswaran J; Krishnaswamy G; Kaple RK; Dolney DO; Blackstone EH
Ann Thorac Surg; 2008 Jan; 85(1):127-33. PubMed ID: 18154797
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]